Overview
Product name | Recombinant Human IGFBP-8/CTGF Protein |
---|
Catalog No. | RP01113 |
---|
Description | Recombinant Human IGFBP-8/CTGF Protein is produced by Mammalian expression system. The target protein is expressed with sequence (Gln27-Ala180) of human CTGF (Accession #P29279) fused with no tags. |
---|
Purity | > 95% by SDS-PAGE. |
---|
Endotoxin | < 1.0 EU/μg of the protein by LAL method. |
---|
Formulation | Lyophilized from a 0.22 μm filtered solution of PBS, pH7.4.Contact us for customized product form or formulation. |
---|
Species | Human |
---|
Calculated MW | 16.3 kDa |
---|
Background
This protein is a mitogen that is secreted by vascular endothelial cells. The encoded protein plays a role in chondrocyte proliferation and differentiation, cell adhesion in many cell types, and is related to platelet-derived growth factor. Certain polymorphisms in this gene have been linked with a higher incidence of systemic sclerosis.
Product information
Synonym | CTGF; CCN2; HCS24; IGFBP8; NOV2 |
---|
Expression Host | HEK293 cells |
---|
Tag | No tag |
---|
Swiss-Prot | |
---|
Gene ID | |
---|
Usage guide
Storage | Store at -20℃.Store the lyophilized protein at -20℃ to -80 ℃ up to 1 year from the date of receipt. After reconstitution, the protein solution is stable at -20℃ for 3 months, at 2-8℃ for up to 1 week. |
---|
Reconstitution | Centrifuge the tube before opening. Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water. Avoid vortex or vigorously pipetting the protein. For long term storage, it is recommended to add a carrier protein or stablizer (e.g. 0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose), and aliquot the reconstituted protein solution to minimize free-thaw cycles. |
---|
* For research use only. Not for therapeutic or diagnostic purposes.